The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Thanks Invest. It has been over 2 months since BC started selling our tests in US and EU. It is hard to believe that they have not sold anything. It is more of a case of sales not been declared to us.
Cant wait for this week to finish. Has been a frustrating ride. Indian approval gains made no difference whatsoever. I hope next week will bring some comfort.
You have seriously lost it Jay! You seems to have entered into delirium stage.
Just to make you feel better, I have more invested here than you with worse average. I am 43% down currently. If I sell now, I may save 5-10% if we go even lower than today but I don't see it going below 60p. On the other hand, the chances of upside from here is better. The only question is when. As I said before, I will wait till end of June.
In the end it is your call.
This is a joke. They are taking us for a ride. Agree that there is no sales figure but the fundamentals are better than 2 weeks ago with Indian approval. Next news will be distribution agreements in India. Don't understand the SP movements
Guy: I recommend it to you and Jay. It will take your pain away. I can help you both get some..
To be honest Guy, even you have some hidden faith that we will do just fine. Otherwise you would have given up. I know this is your only investment! Just throw the phone and go out or sleep for few hours. It will make you feel good. GDR is not going bust anytime soon.
Of course there is another possible conspiracy to the current SP level: it is plausible that Danaher will buy GDR. DB knows this and has been stopped from buying any shares but may have been promised good bonus. It is much easier to buy a failing company for cheap than a successful company so there is vested interest from all parties to do nothing about dropping SP (GDR has done nothing to reassure shareholders. Compare that with avct and ncyt, they issued rns within few days to calm down the market).
The shareholders will eagerly take 200p from where we are now but they won't if SP was 150p. DB or his team seems to be least bothered with the current SP drop and may be intentionally making effort to keep it down with dull or no news.
Also remember that 2/3rd of GDR test money will be going to Danaher.
Just a thought. The world is flat anyway, I don't want any opinion on that question
I tried to stay away from blaming DB for everything but it is very obvious that investor relations is not his field. He has done a **** job with the quality of RNSs so far. I still don't understand why you would omit potential revenue. As a private company, it is his duty to be open with investors. On the other side, he may be cooking something nicer...
Risk: India is an interesting place for business. There is big demand for premium products and reasonable proportion on people will pay extra to have the quality and accuracy.
GDR kit comes at around £10 which gives enough margin to the labs. Coupled with increased throughput with less staff.
I don't think GDR will capture the market but will get enough out to take us over 100p.